Guardian Pharmacy Services (GRDN) concentration risks

The company's disclosed concentration profile is defined by a single, large-share customer-segment dependency: more than two-thirds of annual revenue for each of the past three years has been generated from residents of assisted living facilities and behavioral health facilities. The character of this exposure is structural — it reflects the company's deliberate market positioning as a specialist pharmacy serving congregate care settings rather than retail or mail-order patients — but the structural nature does not make it benign. Because residents of these facility types represent the dominant revenue source, the company's financial performance is closely tied to the occupancy, funding, and regulatory environment of the assisted living and behavioral health facility sectors. Medicaid and Medicare reimbursement changes, facility closures, or enrollment shifts that reduce the number of patients in those care settings would compress the revenue base directly. The dependency character is also present because individual facility relationships — particularly larger operator groups — can represent meaningful shares of individual pharmacy locations' volumes, and operator consolidation or contract losses would have concentrated impacts. No geographic, supplier, or individual counterparty concentrations are disclosed beyond the segment-level customer profile. The overall picture is a business with a high share of revenue tied to a specific patient care segment, where growth and risk are both primarily functions of the structural dynamics of the U.S. long-term and behavioral care market. This is the axis most worth monitoring from a concentration-risk perspective.

For the engine’s reasoning on GRDN’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.